ESH AL 2020 | The impact of germline mutations on AML managment

Name: The impact of germline mutations on AML managment
Uploaded: 2020-07-01T00:00:00Z
Duration: 1 min 41 s
Description: Lucy Godley, MD, PhD, University of Chicago, Chicago, IL, discusses how the distinction between somatic and germline mutations has a significant impact on the patient’s management as well as important implications for their family members. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Lucy Godley • 1 Jul 2020

ESH AL 2020

Acute Myeloid Leukemia Leukemia

Lucy Godley, MD, PhD, University of Chicago, Chicago, IL, discusses how the distinction between somatic and germline mutations has a significant impact on the patient’s management as well as important implications for their family members. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).